These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37674495)

  • 1. The 2023 Impact of Inflammatory Bowel Disease in Canada: Indirect (Individual and Societal) and Direct Out-of-Pocket Costs.
    Kuenzig ME; Im JHB; Coward S; Windsor JW; Kaplan GG; Murthy SK; Benchimol EI; Bernstein CN; Bitton A; Jones JL; Lee K; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Jones May T; Tabatabavakili S; Jogendran R; Weinstein J; Khan R; Hazan E; Browne M; Davis T; Goddard Q; Gorospe J; Latos K; Mason K; Kerr J; Balche N; Sklar A; Targownik LE
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S16-S22. PubMed ID: 37674495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary.
    Windsor JW; Kuenzig ME; Murthy SK; Bitton A; Bernstein CN; Jones JL; Lee K; Targownik LE; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Im JHB; Davis T; Weinstein J; Goddard Q; Benchimol EI; Kaplan GG
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S1-S8. PubMed ID: 37674500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn's Disease or Ulcerative Colitis in the United States.
    Ding Z; Muser E; Izanec J; Lukanova R; Kershaw J; Roughley A
    Crohns Colitis 360; 2022 Jul; 4(3):otac023. PubMed ID: 36777416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease-related economic costs due to presenteeism and absenteeism.
    Rankala R; Mattila K; Voutilainen M; Mustonen A
    Scand J Gastroenterol; 2021 Jun; 56(6):687-692. PubMed ID: 33826877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease.
    Shafer LA; Shaffer S; Witt J; Nugent Z; Bernstein CN
    Inflamm Bowel Dis; 2022 Aug; 28(8):1189-1197. PubMed ID: 34636400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life, work productivity and costs related to patients with inflammatory bowel disease in Austria.
    Walter E; Hausberger SC; Groß E; Siebert U
    J Med Econ; 2020 Oct; 23(10):1061-1071. PubMed ID: 32713223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect and Out-of-Pocket Disease-associated Costs in Pediatric Inflammatory Bowel Disease: A Cross-sectional Analysis.
    El-Matary W; Witt J; Bernstein CN; Jacobson K; Mack D; Otley A; Walters TD; Huynh HQ; deBruyn J; Griffiths AM; Benchimol EI
    J Pediatr Gastroenterol Nutr; 2022 Oct; 75(4):466-472. PubMed ID: 35758424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact.
    Zand A; van Deen WK; Inserra EK; Hall L; Kane E; Centeno A; Choi JM; Ha CY; Esrailian E; DʼHaens GR; Hommes DW
    Inflamm Bowel Dis; 2015 Jul; 21(7):1623-30. PubMed ID: 26070004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease: a Canadian burden of illness review.
    Rocchi A; Benchimol EI; Bernstein CN; Bitton A; Feagan B; Panaccione R; Glasgow KW; Fernandes A; Ghosh S
    Can J Gastroenterol; 2012 Nov; 26(11):811-7. PubMed ID: 23166905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs.
    Kuenzig ME; Coward S; Targownik LE; Murthy SK; Benchimol EI; Windsor JW; Bernstein CN; Bitton A; Jones JL; Lee K; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Im JHB; Jogendran R; Meka S; Weinstein J; Jones May T; Jogendran M; Tabatabavakili S; Hazan E; Hu M; Osei JA; Khan R; Wang G; Browne M; Davis T; Goddard Q; Gorospe J; Latos K; Mason K; Kerr J; Balche N; Sklar A; Kaplan GG
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S23-S34. PubMed ID: 37674493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study.
    van Gennep S; Evers SW; Rietdijk ST; Gielen ME; de Boer NKH; Gecse KB; Ponsioen CIJ; Duijvestein M; D'Haens GR; de Boer AGEM; Löwenberg M
    Inflamm Bowel Dis; 2021 Feb; 27(3):352-363. PubMed ID: 32378704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caregiving-Related Work Productivity Loss Among Employed Family and Other Unpaid Caregivers of Older Adults.
    Keita Fakeye MB; Samuel LJ; Drabo EF; Bandeen-Roche K; Wolff JL
    Value Health; 2023 May; 26(5):712-720. PubMed ID: 35973924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect costs and public finance consequences of heart failure in Poland, 2012-2015.
    Łyszczarz B
    BMC Public Health; 2018 Sep; 18(1):1130. PubMed ID: 30231932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Impact of Pediatric Inflammatory Bowel Disease on Caregivers' Work Productivity and Daily Activities: An International Prospective Study.
    Klomberg RCW; Aardoom MA; Kemos P; Rizopoulos D; Ruemmele FM; Croft NM; de Ridder L; Neyt M;
    J Pediatr; 2022 Jul; 246():95-102.e4. PubMed ID: 35429506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of inflammatory bowel disease in Germany.
    Stark R; König HH; Leidl R
    Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.
    Nguyen GC; Targownik LE; Singh H; Benchimol EI; Bitton A; Murthy SK; Bernstein CN; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S68-S72. PubMed ID: 31294386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.